ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY

Tes Pharma Will Use the elive™ Platform to Functionally Evaluate Response to TES-4207 in Live Tumor Fragments as a Monotherapy and in Combination With Immune Checkpoint Inhibitors MADISON, Wis., Sept. 24, 2026 /PRNewswire/ -- Elephas Biosci…

Summary from PR Newswire - Clinical Trials.

Coverage 1 article · 1 outlet

1. PR Newswire - Clinical Trials 13h ago
   ELEPHAS BIOSCIENCES AND TES PHARMA COLLABORATE TO ADVANCE TRANSLATIONAL RESEARCH FOR LUNG CANCER THERAPY ↗